Alane P. Barnes, Chief Legal Officer at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 323,360 shares at $7.10 ($2.3M) on 2025-12-01, disclosed to the SEC on 2025-12-03.
Scheduled sale ($2.3M) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.10 | 91,004 | $646K | 27.7% |
| 2 | $7.10 | 91,004 | $646K | 27.7% |
| 3 | $7.21 | 50,906 | $367K | 15.8% |
| 4 | $7.21 | 50,906 | $367K | 15.8% |
| 5 | $7.65 | 19,770 | $151K | 6.5% |
| 6 | $7.65 | 19,770 |
| $151K |
| 6.5% |
| Total | $7.20 avg | 323,360 | $2.3M | 100% |
| Filing → |
| BCRX | SELL | 2025-12-23 | $333K | — | Filing → |
| BCRX | SELL | 2025-12-16 | $325K | — | Filing → |
| BCRX | BUY | 2024-05-15 | $28K | — | Filing → |